Keywords: Chronic urticaria; Biologics; Omalizumab; Therapy; Rituximab; TNF antagonist; Intravenous immunoglobulin therapy;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ADA; adalimumab; AEs; adverse events; AZA; azathioprine; CI; confidence interval; Cy; cyclosporine; CNS; central nervous system; CS; corticosteroids; CYC; cyclophosphamide; CZP; certolizumab pegol; ePOST; Extrapulmonary Physician Organ Severity Tool; ETN;
Reprint of “Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab”
Keywords: AS; ankylosing spondylitis; ATA; anti-therapeutic antibodies; BASDAI; Bath Ankylosing Spondylitis Disease Activity Index; DAS28; Disease Activity Score 28; DMARDs; disease-modifying antirheumatic drugs; ECL; electrochemiluminescence; LoD; limit of detecti
Mucosal Healing and Long-term Outcomes of Patients With Inflammatory Bowel Diseases Receiving Clinic-Based vs Trough Concentration-Based Dosing of Infliximab
Keywords: Endoscopic; TNF Antagonist; Therapeutic Drug Monitoring; Optimization; ATI; antibody to infliximab; CD; Crohn's disease; IBD; inflammatory bowel disease; IQR; interquartile range; TAXIT; Trough Concentration Adapted Infliximab Treatment; TDM; therapeuti
Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab
Keywords: AS; ankylosing spondylitis; ATA; anti-therapeutic antibodies; BASDAI; Bath Ankylosing Spondylitis Disease Activity Index; DAS28; Disease Activity Score 28; DMARDs; disease-modifying antirheumatic drugs; ECL; electrochemiluminescence; LoD; limit of detecti
Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
Keywords: Inflammatory Bowel Disease; TNF Antagonist; Human Monoclonal Antibody; Dose−ResponseAZA, azathioprine; CRP, C-reactive protein; IBDQ, Inflammatory Bowel Disease Questionnaire; PK, pharmacokinetic; PURSUIT-SC, Program of Ulcerative Colitis Research Studies
Efficacy and Safety of TNF Antagonists in Sarcoidosis: Data from the Spanish Registry of Biologics BIOBADASER and a Systematic Review
Keywords: sarcoidosis; TNF antagonist; efficacy; effectiveness; safety
Therapeutic considerations in spondyloarthritis patients who fail tumour necrosis factor antagonists
Keywords: spondyloarthritis; psoriatic arthritis; ankylosing spondylitis; TNF antagonist; failure; treatment